NASDAQ:CLPT

Clearpoint Neuro Stock News

Healthcare > Medical - Devices

Buy CLPT

*Your capital is at risk

$14.94

+0.360 (+2.47%)

At Close: Jul 31, 2026

ClearPoint Neuro to Present at Upcoming Investor Conferences

09:25am, Wednesday, 09'th Nov 2022

SOLANA BEACH, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the b

ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue Estimates

08:18pm, Tuesday, 08'th Nov 2022

ClearPoint Neuro, Inc. (CLPT) delivered earnings and revenue surprises of 21.05% and 6.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the sto

ClearPoint Neuro, Inc. (CLPT) Q3 2022 Earnings Call Transcript

06:15pm, Tuesday, 08'th Nov 2022

ClearPoint Neuro, Inc. (NASDAQ:CLPT ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Joe Burnett - CEO Danilo D'Alessandro - CFO Conference Call Participants William

ClearPoint Neuro: Continuous Great Execution

12:56pm, Monday, 19'th Sep 2022

Revenue growth rebounded strongly due to its acceleration in B&DD and capital equipment and software revenue. The company marks its first milestone with its FDA approval with PTC-AADC, with certainly

2 Stocks Under $20 to Watch

11:20am, Saturday, 17'th Sep 2022

Here are two interesting companies under $20.

ClearPoint Neuro: Picks & Shovels Galore

05:11pm, Friday, 19'th Aug 2022

Shares have lost 20% of their value since the initial public offering in February of last year. The company is well-positioned as a "picks and shovels" play to pharmaceutical partners addressing neuro

ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Tops Revenue Estimates

09:04pm, Tuesday, 09'th Aug 2022

ClearPoint Neuro, Inc. (CLPT) delivered earnings and revenue surprises of 0% and 0.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ClearPoint Neuro, Inc. (CLPT) CEO Joe Burnett on Q2 2022 Results - Earnings Call Transcript

07:18pm, Tuesday, 09'th Aug 2022

ClearPoint Neuro, Inc. (NASDAQ:CLPT ) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Joe Burnett - Chief Executive Officer Danilo D'Alessandro - Chief Financial Office

ClearPoint Neuro: A 'Picks And Shovels' Biotech Company

04:12am, Monday, 25'th Jul 2022

CLPT has been growing revenues steadily and has a large addressable market. It also has a very strong moat due to the nature of the FDA approval process.

ClearPoint Neuro, Inc. (CLPT) Surges 7.6%: Is This an Indication of Further Gains?

09:14am, Monday, 27'th Jun 2022

ClearPoint Neuro, Inc. (CLPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the

ClearPoint Neuro to Present Investigational Research and Exhibit at the American Society of Gene & Cell Therapy Annual Meeting in Washington, DC

09:25am, Friday, 13'th May 2022

SOLANA BEACH, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the br

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by